The company said Americas Clear Aligner case revenues for fiscal 2023 were $1,463.0 million, down 0.6% year over year, while International case revenues were $1,449.5 million, up 7.4%.

1. 01

   The company said Americas Clear Aligner case revenues for fiscal 2023 were $1,463.0 million, down 0.6% year over year, while International case revenues were $1,449.5 million, up 7.4%.

2. 02

   Americas net revenues fell $9.0 million in 2023, the company said. It cited a 2.1% decline in case volume, which reduced net revenues by $31.4 million, and a $22.4 million increase from higher ASP.

3. 03

   ALGN said net income for fiscal 2023 was $445.1 million, diluted net income per share was $5.81, and cash flow from operating activities was $785.8 million.

4. 04

   The company said net cash used in financing activities was $598.3 million in fiscal 2023, and it paid $602.4 million for share repurchases. About $650.0 million remained available under the repurchase program approved in January 2023.

Key figures

Fiscal year ended December 31, 2023

Revenue

$3.9B

Operating income

$643M

Net income

$445M

EPS

$5.81

Gross profit

$2.7B

Operating cash flow

$786M

Analysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.